OMERSMALL

Omeros Corporation

HealthcareBiotechnology
$10.33
$0.00(-0.10%)
52W$3.06
$17.65
Updated Jul 8, 02:00 AM
RSI50
RS Rating19/99
Beta1.56
Volatility109%
F-Score3/9
Mkt Cap$748M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Omeros Corporation is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 19), showing significant lag compared to the market leaders. Earnings growth of 234% provides fundamental context to the price action. Investors should exercise caution due to high volatility (109% annualized), which requires wider risk management.

Relative Strength
19
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.56
vs S&P 500
HIGH BETA
52W Position
50%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$11.65
50 SMA > 100 SMA$11.60
100 SMA > 150 SMA$11.72
150 SMA > 200 SMA$10.43

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$9.86+4.75%ABOVE
50 SMA$11.65-11.29%BELOW
100 SMA$11.60-10.96%BELOW
150 SMA$11.72-11.84%BELOW
200 SMA$10.43-0.93%BELOW

Price Performance

1D-0.1%
1W+8.6%
1M+4.9%
3M-5.9%
6M-26.7%
YTD-36.9%
1Y+235.4%
3Y+25.1%
52-Week Trading Range50% from low
$10.33
52W Low$3.06
52W High$17.65

Technical Indicators

RSI (14)NEUTRAL
50.2
305070
Setup ScoreCOOL
2/10
Base depth: 83.4%

Risk Profile

Beta
1.56
52W Vol
109%
ATR
$1.07
Max DD (1Y)
-50%

Volume Analysis

Today
1.21M
50D Avg
1.68M
Vol Ratio
0.72x
Liquidity
MODERATE

Earnings Momentum

Q2'25+56%
$-0.43
Q3'25+16%
$-0.47
Q4'25+363%
$1.42
Q1'26+234%
$0.78
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:+30.49%
5 Years:
3 Years:
TTM:+149.06%

Stock Price CAGR

10 Years:-1.16%
5 Years:-6.75%
3 Years:+25.15%
1 Year:+235.39%

Return on Equity

10Y Avg:-168.1%
5Y Avg:-256.7%
3Y Avg:-388.2%
Last Year:

Key Metrics

Market Cap$748M
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is OMER in an uptrend right now?

OMER has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is OMER overbought or oversold?

OMER's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.

Is OMER outperforming the market?

OMER has a Relative Strength (RS) Rating of 19 out of 99. OMER is currently lagging the broader market.

Where is OMER in its 52-week range?

OMER is trading at $10.33, which is 59% of its 52-week high ($17.65) and 50% above its 52-week low ($3.06).

How volatile is OMER?

OMER has a Beta of 1.56 and 52-week volatility of 109%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.